United States Regenerative Medicine Products Market Report & Forecast 2021-2027

United States Regenerative Medicine Products Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Regenerative Medicine Products Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Regenerative Medicine Products Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Regenerative Medicine Products Overall Market Size
2.1 United States Regenerative Medicine Products Market Size: 2021 VS 2027
2.2 United States Regenerative Medicine Products Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Regenerative Medicine Products Sales: 2016-2027
3 Company Landscape
3.1 Top Regenerative Medicine Products Players in United States Market
3.2 Top United States Regenerative Medicine Products Companies Ranked by Revenue
3.3 United States Regenerative Medicine Products Revenue by Companies
3.4 United States Regenerative Medicine Products Sales by Companies
3.5 United States Regenerative Medicine Products Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Regenerative Medicine Products Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Regenerative Medicine Products Product Type
3.8 Tier 1, Tier 2 and Tier 3 Regenerative Medicine Products Players in United States Market
3.8.1 List of Tier 1 Regenerative Medicine Products Companies in United States
3.8.2 List of Tier 2 and Tier 3 Regenerative Medicine Products Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Regenerative Medicine Products Market Size Markets, 2021 & 2027
4.1.2 Cell Therapy
4.1.3 Tissue Engineering
4.1.4 Biomaterial
4.1.5 Others
4.2 By Type - United States Regenerative Medicine Products Revenue & Forecasts
4.2.1 By Type - United States Regenerative Medicine Products Revenue, 2016-2021
4.2.2 By Type - United States Regenerative Medicine Products Revenue, 2022-2027
4.2.3 By Type - United States Regenerative Medicine Products Revenue Market Share, 2016-2027
4.3 By Type - United States Regenerative Medicine Products Sales & Forecasts
4.3.1 By Type - United States Regenerative Medicine Products Sales, 2016-2021
4.3.2 By Type - United States Regenerative Medicine Products Sales, 2022-2027
4.3.3 By Type - United States Regenerative Medicine Products Sales Market Share, 2016-2027
4.4 By Type - United States Regenerative Medicine Products Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Regenerative Medicine Products Market Size, 2021 & 2027
5.1.2 Dermatology
5.1.3 Cardiovascular
5.1.4 CNS
5.1.5 Orthopedic
5.1.6 Others
5.2 By Application - United States Regenerative Medicine Products Revenue & Forecasts
5.2.1 By Application - United States Regenerative Medicine Products Revenue, 2016-2021
5.2.2 By Application - United States Regenerative Medicine Products Revenue, 2022-2027
5.2.3 By Application - United States Regenerative Medicine Products Revenue Market Share, 2016-2027
5.3 By Application - United States Regenerative Medicine Products Sales & Forecasts
5.3.1 By Application - United States Regenerative Medicine Products Sales, 2016-2021
5.3.2 By Application - United States Regenerative Medicine Products Sales, 2022-2027
5.3.3 By Application - United States Regenerative Medicine Products Sales Market Share, 2016-2027
5.4 By Application - United States Regenerative Medicine Products Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Acelity
6.1.1 Acelity Corporation Information
6.1.2 Acelity Overview
6.1.3 Acelity Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.1.4 Acelity Regenerative Medicine Products Product Description
6.1.5 Acelity Recent Developments
6.2 DePuy Synthes
6.2.1 DePuy Synthes Corporation Information
6.2.2 DePuy Synthes Overview
6.2.3 DePuy Synthes Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.2.4 DePuy Synthes Regenerative Medicine Products Product Description
6.2.5 DePuy Synthes Recent Developments
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Overview
6.3.3 Medtronic Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.3.4 Medtronic Regenerative Medicine Products Product Description
6.3.5 Medtronic Recent Developments
6.4 ZimmerBiomet
6.4.1 ZimmerBiomet Corporation Information
6.4.2 ZimmerBiomet Overview
6.4.3 ZimmerBiomet Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.4.4 ZimmerBiomet Regenerative Medicine Products Product Description
6.4.5 ZimmerBiomet Recent Developments
6.5 Stryker
6.5.1 Stryker Corporation Information
6.5.2 Stryker Overview
6.5.3 Stryker Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.5.4 Stryker Regenerative Medicine Products Product Description
6.5.5 Stryker Recent Developments
6.6 MiMedx Group
6.6.1 MiMedx Group Corporation Information
6.6.2 MiMedx Group Overview
6.6.3 MiMedx Group Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.6.4 MiMedx Group Regenerative Medicine Products Product Description
6.6.5 MiMedx Group Recent Developments
6.7 Organogenesis
6.7.1 Organogenesis Corporation Information
6.7.2 Organogenesis Overview
6.7.3 Organogenesis Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.7.4 Organogenesis Regenerative Medicine Products Product Description
6.7.5 Organogenesis Recent Developments
6.8 UniQure
6.8.1 UniQure Corporation Information
6.8.2 UniQure Overview
6.8.3 UniQure Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.8.4 UniQure Regenerative Medicine Products Product Description
6.8.5 UniQure Recent Developments
6.9 Cellular Dynamics International
6.9.1 Cellular Dynamics International Corporation Information
6.9.2 Cellular Dynamics International Overview
6.9.3 Cellular Dynamics International Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.9.4 Cellular Dynamics International Regenerative Medicine Products Product Description
6.9.5 Cellular Dynamics International Recent Developments
6.10 Osiris Therapeutics
6.10.1 Osiris Therapeutics Corporation Information
6.10.2 Osiris Therapeutics Overview
6.10.3 Osiris Therapeutics Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.10.4 Osiris Therapeutics Regenerative Medicine Products Product Description
6.10.5 Osiris Therapeutics Recent Developments
6.11 Vcanbio
6.11.1 Vcanbio Corporation Information
6.11.2 Vcanbio Overview
6.11.3 Vcanbio Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.11.4 Vcanbio Regenerative Medicine Products Product Description
6.11.5 Vcanbio Recent Developments
6.12 Gamida Cell
6.12.1 Gamida Cell Corporation Information
6.12.2 Gamida Cell Overview
6.12.3 Gamida Cell Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.12.4 Gamida Cell Regenerative Medicine Products Product Description
6.12.5 Gamida Cell Recent Developments
6.13 Golden Meditech
6.13.1 Golden Meditech Corporation Information
6.13.2 Golden Meditech Overview
6.13.3 Golden Meditech Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.13.4 Golden Meditech Regenerative Medicine Products Product Description
6.13.5 Golden Meditech Recent Developments
6.14 Cytori Therapeutics
6.14.1 Cytori Therapeutics Corporation Information
6.14.2 Cytori Therapeutics Overview
6.14.3 Cytori Therapeutics Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.14.4 Cytori Therapeutics Regenerative Medicine Products Product Description
6.14.5 Cytori Therapeutics Recent Developments
6.15 Celgene
6.15.1 Celgene Corporation Information
6.15.2 Celgene Overview
6.15.3 Celgene Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.15.4 Celgene Regenerative Medicine Products Product Description
6.15.5 Celgene Recent Developments
6.16 Vericel Corporation
6.16.1 Vericel Corporation Corporation Information
6.16.2 Vericel Corporation Overview
6.16.3 Vericel Corporation Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.16.4 Vericel Corporation Regenerative Medicine Products Product Description
6.16.5 Vericel Corporation Recent Developments
6.17 Guanhao Biotech
6.17.1 Guanhao Biotech Corporation Information
6.17.2 Guanhao Biotech Overview
6.17.3 Guanhao Biotech Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.17.4 Guanhao Biotech Regenerative Medicine Products Product Description
6.17.5 Guanhao Biotech Recent Developments
6.18 Mesoblast
6.18.1 Mesoblast Corporation Information
6.18.2 Mesoblast Overview
6.18.3 Mesoblast Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.18.4 Mesoblast Regenerative Medicine Products Product Description
6.18.5 Mesoblast Recent Developments
6.19 Stemcell Technologes
6.19.1 Stemcell Technologes Corporation Information
6.19.2 Stemcell Technologes Overview
6.19.3 Stemcell Technologes Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.19.4 Stemcell Technologes Regenerative Medicine Products Product Description
6.19.5 Stemcell Technologes Recent Developments
6.20 Bellicum Pharmaceuticals
6.20.1 Bellicum Pharmaceuticals Corporation Information
6.20.2 Bellicum Pharmaceuticals Overview
6.20.3 Bellicum Pharmaceuticals Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.20.4 Bellicum Pharmaceuticals Regenerative Medicine Products Product Description
6.20.5 Bellicum Pharmaceuticals Recent Developments
7 United States Regenerative Medicine Products Production Capacity, Analysis
7.1 United States Regenerative Medicine Products Production Capacity, 2016-2027
7.2 Regenerative Medicine Products Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Regenerative Medicine Products Supply Chain Analysis
9.1 Regenerative Medicine Products Industry Value Chain
9.2 Regenerative Medicine Products Upstream Market
9.3 Regenerative Medicine Products Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Regenerative Medicine Products Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Regenerative Medicine Products in United States Market
Table 2. Top Regenerative Medicine Products Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Regenerative Medicine Products Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Regenerative Medicine Products Revenue Share by Companies, 2016-2021
Table 5. United States Regenerative Medicine Products Sales by Companies, (Units), 2016-2021
Table 6. United States Regenerative Medicine Products Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Regenerative Medicine Products Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Regenerative Medicine Products Product Type
Table 9. List of Tier 1 Regenerative Medicine Products Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Regenerative Medicine Products Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Cell Therapy
Table 12. Major Manufacturers of Tissue Engineering
Table 13. By Type - United States Regenerative Medicine Products Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Regenerative Medicine Products Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Regenerative Medicine Products Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Regenerative Medicine Products Sales (Units), 2016-2021
Table 17. By Type - United States Regenerative Medicine Products Sales (Units), 2022-2027
Table 18. By Application - United States Regenerative Medicine Products Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Regenerative Medicine Products Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Regenerative Medicine Products Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Regenerative Medicine Products Sales (Units), 2016-2021
Table 22. By Application - United States Regenerative Medicine Products Sales (Units), 2022-2027
Table 23. Acelity Corporation Information
Table 24. Acelity Description and Major Businesses
Table 25. Acelity Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Acelity Regenerative Medicine Products Product
Table 27. Acelity Recent Developments
Table 28. DePuy Synthes Corporation Information
Table 29. DePuy Synthes Description and Major Businesses
Table 30. DePuy Synthes Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. DePuy Synthes Regenerative Medicine Products Product
Table 32. DePuy Synthes Recent Developments
Table 33. Medtronic Corporation Information
Table 34. Medtronic Description and Major Businesses
Table 35. Medtronic Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Medtronic Regenerative Medicine Products Product
Table 37. Medtronic Recent Developments
Table 38. ZimmerBiomet Corporation Information
Table 39. ZimmerBiomet Description and Major Businesses
Table 40. ZimmerBiomet Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. ZimmerBiomet Regenerative Medicine Products Product
Table 42. ZimmerBiomet Recent Developments
Table 43. Stryker Corporation Information
Table 44. Stryker Description and Major Businesses
Table 45. Stryker Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Stryker Regenerative Medicine Products Product
Table 47. Stryker Recent Developments
Table 48. MiMedx Group Corporation Information
Table 49. MiMedx Group Description and Major Businesses
Table 50. MiMedx Group Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. MiMedx Group Regenerative Medicine Products Product
Table 52. MiMedx Group Recent Developments
Table 53. Organogenesis Corporation Information
Table 54. Organogenesis Description and Major Businesses
Table 55. Organogenesis Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Organogenesis Regenerative Medicine Products Product
Table 57. Organogenesis Recent Developments
Table 58. UniQure Corporation Information
Table 59. UniQure Description and Major Businesses
Table 60. UniQure Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. UniQure Regenerative Medicine Products Product
Table 62. UniQure Recent Developments
Table 63. Cellular Dynamics International Corporation Information
Table 64. Cellular Dynamics International Description and Major Businesses
Table 65. Cellular Dynamics International Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Cellular Dynamics International Regenerative Medicine Products Product
Table 67. Cellular Dynamics International Recent Developments
Table 68. Osiris Therapeutics Corporation Information
Table 69. Osiris Therapeutics Description and Major Businesses
Table 70. Osiris Therapeutics Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Osiris Therapeutics Regenerative Medicine Products Product
Table 72. Osiris Therapeutics Recent Developments
Table 73. Vcanbio Corporation Information
Table 74. Vcanbio Description and Major Businesses
Table 75. Vcanbio Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Vcanbio Regenerative Medicine Products Product
Table 77. Vcanbio Recent Developments
Table 78. Gamida Cell Corporation Information
Table 79. Gamida Cell Description and Major Businesses
Table 80. Gamida Cell Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. Gamida Cell Regenerative Medicine Products Product
Table 82. Gamida Cell Recent Developments
Table 83. Golden Meditech Corporation Information
Table 84. Golden Meditech Description and Major Businesses
Table 85. Golden Meditech Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 86. Golden Meditech Regenerative Medicine Products Product
Table 87. Golden Meditech Recent Developments
Table 88. Cytori Therapeutics Corporation Information
Table 89. Cytori Therapeutics Description and Major Businesses
Table 90. Cytori Therapeutics Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 91. Cytori Therapeutics Regenerative Medicine Products Product
Table 92. Cytori Therapeutics Recent Developments
Table 93. Celgene Corporation Information
Table 94. Celgene Description and Major Businesses
Table 95. Celgene Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 96. Celgene Regenerative Medicine Products Product
Table 97. Celgene Recent Developments
Table 98. Vericel Corporation Corporation Information
Table 99. Vericel Corporation Description and Major Businesses
Table 100. Vericel Corporation Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 101. Vericel Corporation Regenerative Medicine Products Product
Table 102. Vericel Corporation Recent Developments
Table 103. Guanhao Biotech Corporation Information
Table 104. Guanhao Biotech Description and Major Businesses
Table 105. Guanhao Biotech Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 106. Guanhao Biotech Regenerative Medicine Products Product
Table 107. Guanhao Biotech Recent Developments
Table 108. Mesoblast Corporation Information
Table 109. Mesoblast Description and Major Businesses
Table 110. Mesoblast Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 111. Mesoblast Regenerative Medicine Products Product
Table 112. Mesoblast Recent Developments
Table 113. Stemcell Technologes Corporation Information
Table 114. Stemcell Technologes Description and Major Businesses
Table 115. Stemcell Technologes Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 116. Stemcell Technologes Regenerative Medicine Products Product
Table 117. Stemcell Technologes Recent Developments
Table 118. Bellicum Pharmaceuticals Corporation Information
Table 119. Bellicum Pharmaceuticals Description and Major Businesses
Table 120. Bellicum Pharmaceuticals Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 121. Bellicum Pharmaceuticals Regenerative Medicine Products Product
Table 122. Bellicum Pharmaceuticals Recent Developments
Table 123. Regenerative Medicine Products Production Capacity (Units) of Key Manufacturers in United States Market, 2019-2021 (Units)
Table 124. United States Regenerative Medicine Products Capacity Market Share of Key Manufacturers, 2019-2021
Table 125. Regenerative Medicine Products Market Opportunities & Trends in United States Market
Table 126. Regenerative Medicine Products Market Drivers in United States Market
Table 127. Regenerative Medicine Products Market Restraints in United States Market
Table 128. Regenerative Medicine Products Raw Materials
Table 129. Regenerative Medicine Products Raw Materials Suppliers in United States Market
Table 130. Typical Regenerative Medicine Products Downstream
Table 131. Regenerative Medicine Products Downstream Clients in United States Market
Table 132. Regenerative Medicine Products Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Regenerative Medicine Products Product Picture
Figure 2. Regenerative Medicine Products Segment by Type
Figure 3. Regenerative Medicine Products Segment by Application
Figure 4. United States Regenerative Medicine Products Market Overview: 2020
Figure 5. United States Regenerative Medicine Products Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Regenerative Medicine Products Revenue, 2016-2027 (US$, Mn)
Figure 7. Regenerative Medicine Products Sales in United States Market: 2016-2027 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Regenerative Medicine Products Revenue in 2020
Figure 9. Cell Therapy Product Picture
Figure 10. Tissue Engineering Product Picture
Figure 11. Biomaterial Product Picture
Figure 12. Others Product Picture
Figure 13. By Type - United States Regenerative Medicine Products Sales Market Share, 2016-2027
Figure 14. By Type - United States Regenerative Medicine Products Revenue Market Share, 2016-2027
Figure 15. By Type - United States Regenerative Medicine Products Price (USD/Unit), 2016-2027
Figure 16. Dermatology
Figure 17. Cardiovascular
Figure 18. CNS
Figure 19. Orthopedic
Figure 20. Others
Figure 21. By Application - United States Regenerative Medicine Products Sales Market Share, 2016-2027
Figure 22. By Application - United States Regenerative Medicine Products Revenue Market Share, 2016-2027
Figure 23. By Application - United States Regenerative Medicine Products Price (USD/Unit), 2016-2027
Figure 24. Acelity Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. DePuy Synthes Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Medtronic Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. ZimmerBiomet Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Stryker Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. MiMedx Group Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Organogenesis Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. UniQure Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Cellular Dynamics International Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Osiris Therapeutics Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Vcanbio Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Gamida Cell Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Golden Meditech Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Cytori Therapeutics Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Celgene Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Vericel Corporation Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Guanhao Biotech Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Mesoblast Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Stemcell Technologes Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Bellicum Pharmaceuticals Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. United States Regenerative Medicine Products Production Capacity (Units), 2016-2027
Figure 45. Regenerative Medicine Products Industry Value Chain
Figure 46. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Tissue Engineered Skin Substitutes Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global Tissue Engineered Skin Substitutes market was valued at US$ 1571.8 million in 2023 and is anticipated to reach US$ 3109.6 million by 2030, witnessing a CAGR of 9.8% during The forecast period 2024-2030. North American market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Tissue Engineered Skin Substitutes is est......

Global Tissue Engineering Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Tissue Engineering market size was valued at US$ 26430 million in 2023. With growing demand in downstream market, the Tissue Engineering is forecast to a readjusted size of US$ 90330 million by 2030 with a CAGR of 19.2% during review period. The research report highlights the growth potential of the global Tissue Engineering market. Tissue Engineering are expected to show stable growth in the future market. However, product d......

Global Regenerative Medicine Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 150

According to our LPI (LP Information) latest study, the global Regenerative Medicine market size was valued at US$ 32640 million in 2023. With growing demand in downstream market, the Regenerative Medicine is forecast to a readjusted size of US$ 116410 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Regenerative Medicine market. Regenerative Medicine are expected to show stable growth in the future market. Howev......

Global Tissue Engineered Skin Substitutes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Tissue Engineered Skin Substitutes market: According to our latest research, the global Tissue Engineered Skin Substitutes market looks promising in the next 5 years. As of 2022, the global Tissue Engineered Skin Substitutes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tissue-engineered skin substitutes have become viable as a suitable alternative to auto- ......

Regenerative Medicine Products - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 121

The global Regenerative Medicine Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Medicine Products in various end use industries. The expanding demands from the Dermatology, Cardiovascular, CNS and Orthopedic, are propelling Regenerative Medicine Products market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ ......

Tissue Engineered Skin Substitutes - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 96

The global Tissue Engineered Skin Substitutes market size is expected to reach US$ 3109.6 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Engineered Skin Substitutes in various end use industries. The expanding demands from the Burn Injury, Diabetic, Vascular Ulcer and Others, are propelling Tissue Engineered Skin Substitutes market. Acellular, one of the segments analysed in this report, is projected to record %......

Global Tissue Engineering and Regeneration Market Research Report 2023

Published: 21-Nov-2023        Price: US 2900 Onwards        Pages: 98

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Engineering and Regeneration market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Advanced Cell Technology - Ocata Therapeutics - Arteriocyte - Therapeutics - BioTissue Technologies - Kinetic Concepts - Bi......

Global Tissue Analysis Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Tissue Analysis Products market: According to our latest research, the global Tissue Analysis Products market looks promising in the next 5 years. As of 2022, the global Tissue Analysis Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......

Regenerative Medicine Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 950

Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of regenerative medicine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs